These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7600910)

  • 61. Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal.
    Garrett ER
    J Pharmacokinet Biopharm; 1993 Dec; 21(6):689-734. PubMed ID: 8138893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A modified residual method to estimate the zero-order absorption rate constant in a one-compartment model.
    Liu X; Brouwer KL; Pollack GM
    Biopharm Drug Dispos; 1997 Mar; 18(2):93-101. PubMed ID: 9099446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis.
    Wade JR; Kelman AW; Howie CA; Whiting B
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):209-22. PubMed ID: 8229681
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A computer program (DCN) for numerical convolution and deconvolution of pharmacokinetic functions.
    Lanao JM; Vicente MT; Sayalero ML; Domínguez-Gil A
    J Pharmacobiodyn; 1992 May; 15(5):203-14. PubMed ID: 1527696
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Bialer M
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):111-3. PubMed ID: 7381690
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bias in the Wagner-Nelson estimate of the fraction of drug absorbed.
    Wang Y; Nedelman J
    Pharm Res; 2002 Apr; 19(4):470-6. PubMed ID: 12033382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Investigation of absorption kinetics by the phase plane method.
    Dokoumetzidis A; Macheras P
    Pharm Res; 1998 Aug; 15(8):1262-9. PubMed ID: 9706059
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.
    Wijnand HP
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):109-28. PubMed ID: 3373416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A New Method for the Estimation of Absorption Rate Constant in Two-Compartment Model by Extravascular Administration.
    Zeng Y; Liu J; Liu W; Jiang S; Wang S; Cheng Z
    J Pharm Sci; 2020 May; 109(5):1802-1810. PubMed ID: 32032589
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Improved Formula for Predicting Hemodialyzability of Intravenous and Oral Drugs.
    Murakami M; Narita Y; Urata M; Ichigi M; Nakatani S; Kondo Y; Ishitsuka Y; Irie T; Hirata S
    Blood Purif; 2021; 50(6):865-875. PubMed ID: 33690227
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup.
    Roe DJ
    Stat Med; 1997 Jun; 16(11):1241-57; discussion 1257-62. PubMed ID: 9194270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function.
    Chan KK; Langenbucher F; Gibaldi M
    J Pharm Sci; 1987 Jun; 76(6):446-50. PubMed ID: 3625488
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Propantheline in sustained-release preparations--a doubtful alternative].
    Beermann B; Rosén A
    Lakartidningen; 1972 Jun; 69():Suppl 2:26-8. PubMed ID: 4645696
    [No Abstract]   [Full Text] [Related]  

  • 75. The determination of the absolute bioavailability for drug substances with long elimination half-lives (with PC-programs for the method of truncated areas).
    Wijnand HP
    Comput Methods Programs Biomed; 1992; 39(1-2):61-73. PubMed ID: 1302673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine.
    Davidian M; Gallant AR
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):529-56. PubMed ID: 1287201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The usefulness of compartmental analysis for the development of sustained release drug forms; experiences with drotaverine in humans].
    Rutz-Coudray MH; Balant L; Buri P
    Pharm Acta Helv; 1979; 54(7-8):210-3. PubMed ID: 515108
    [No Abstract]   [Full Text] [Related]  

  • 78. Anomalous parameter estimates in the one-compartment model with first-order absorption.
    Purves RD
    J Pharm Pharmacol; 1993 Oct; 45(10):934-6. PubMed ID: 7904640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pseudoephedrine absorption from controlled release formulations: absorption rate constant estimation methods.
    Graves DA; Rotenberg KS
    Biopharm Drug Dispos; 1989; 10(2):127-36. PubMed ID: 2650751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intestinal absorption kinetics using a laminar flow model.
    Yokokawa M; Nishigaki R; Umemura K; Hayton WL
    J Pharmacobiodyn; 1989 Jun; 12(6):332-40. PubMed ID: 2778626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.